TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Herantis Pharma Oyj
Closing information (x1000 EUR)
| Closing information | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Turnover | 25 | 0 | |
| Financial expenses |
83
|
4,866
|
28 |
| Earnings before taxes |
-4,425
|
-15,487
|
-781 |
| Total assets |
10,205
|
14,341
|
2,641 |
| Current assets |
782
|
415
|
43 |
| Current liabilities |
613
|
375
|
670 |
| Equity capital |
1,575
|
10,658
|
120 |
| - share capital |
80
|
80
|
3 |
| Employees (average) |
7
|
5
|
3 |
Financial ratios
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Solvency |
15.4%
|
74.3%
|
4.5% |
| Turnover per employee | 4 | 0 | |
| Profit as a percentage of turnover | -17700% | ||
| Return on assets (ROA) |
-42.5%
|
-74.1%
|
-28.5% |
| Current ratio |
127.6%
|
110.7%
|
6.4% |
| Return on equity (ROE) |
-281.0%
|
-145.3%
|
-650.8% |
| Change turnover | |||
| Change turnover % | |||
| Chg. No. of employees | |||
| Chg. No. of employees % | 67% |
Total value of public sale
| Fiscal year | 2016/12 (consolidated) | 2015/12 | 2013/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.